Suppr超能文献

墨西哥蒂华纳市甲苯噻嗪的检测:整合药物检测与临床尿液检测数据

The Detection of Xylazine in Tijuana, Mexico: Triangulating Drug Checking and Clinical Urine Testing Data.

作者信息

Friedman Joseph R, Montoya Alejando González, Ruiz Carmina, Tejeda Mariana Alejandra González, Segovia Luis A, Godvin Morgan E, Sisco Edward, Pyfrom Elise M, Appley Meghan G, Shover Chelsea L, Bufanda Lilia Pacheco

机构信息

Department of Psychiatry, University of California, San Diego.

Asociación Bajacaliforniana de Salud Pública A.C., Tijuana, Baja California, México.

出版信息

medRxiv. 2024 Aug 22:2024.08.19.24312273. doi: 10.1101/2024.08.19.24312273.

Abstract

INTRODUCTION

Xylazine is a veterinary anesthetic increasingly present alongside illicit fentanyl in the US and Canada, presenting novel health risks. Although xylazine remains less common in the Western US, Mexican border cities serve as key trafficking hubs and may have higher prevalence of novel substances, but surveillance has been limited.

METHODS

We examined deidentified records from the Prevencasa harm reduction clinic in Tijuana, describing urine and paraphernalia testing from patients reporting using illicit opioids within 24 hr. Xylazine (two types), fentanyl, opiate, methamphetamine, amphetamine, benzodiazepine, and nitazene test strips were used to test urine and paraphernalia samples. Paraphernalia samples were also analyzed with mass spectrometry.

RESULTS

The study consisted of 23 participants that provided both urine and paraphernalia samples. Of the participants studied, 100 %, 91.3 %, and 69.6 % reported using China White/fentanyl, methamphetamine, and tar heroin, respectively. The mean age was 41.7 years, 95.7 % were male, 65.2 % were unhoused, and 30.4 % had skin wounds at the time of sample collection.Xylazine positivity in urine, for the two types used, was 82.6 % and 65.2 %. For paraphernalia testing, the xylazine positivity was 65.2 % and 47.8 %. Confirmatory testing of paraphernalia samples by mass spectrometry indicated a 52.2 % xylazine positivity. This testing also revealed positivity rates for fentanyl (73.9 %), fluorofentanyl (30.4 %), tramadol (30.4 %), and lidocaine (30.4 %).The mass spectrometry results suggest lidocaine triggered = 3 and = 0 false positives among the xylazine test strip types. A total of = 0 and = 1 false negatives were also observed.

DISCUSSION

Xylazine is present on the U.S.-Mexico border, requiring public health intervention. High lidocaine positivity complicates the clinical detection of xylazine via testing strips. Xylazine was found to be more prevalent in urine than in paraphernalia samples. Confirmatory urine studies are needed to better understand possible complications of using test strips for toxicological testing.

摘要

引言

在美国和加拿大,赛拉嗪作为一种兽用麻醉剂,越来越多地与非法芬太尼一同出现,带来了新的健康风险。尽管赛拉嗪在美国西部仍不太常见,但墨西哥边境城市是主要的贩运中心,可能新型物质的流行率更高,但监测一直有限。

方法

我们检查了提华纳Prevencasa减少伤害诊所的匿名记录,描述了在24小时内报告使用非法阿片类药物的患者的尿液和用具检测情况。使用赛拉嗪(两种类型)、芬太尼、阿片类、甲基苯丙胺、苯丙胺、苯二氮卓和硝氮烯试纸对尿液和用具样本进行检测。用具样本也用质谱法进行分析。

结果

该研究包括23名提供尿液和用具样本的参与者。在研究的参与者中,分别有100%、91.3%和69.6%的人报告使用了“中国白”/芬太尼、甲基苯丙胺和焦油海洛因。平均年龄为41.7岁,95.7%为男性,65.2%无家可归,30.4%在采集样本时患有皮肤伤口。所使用的两种类型赛拉嗪在尿液中的阳性率分别为82.6%和65.2%。在用具检测中,赛拉嗪阳性率分别为65.2%和47.8%。通过质谱法对用具样本进行确证检测表明赛拉嗪阳性率为52.2%。该检测还显示了芬太尼(73.9%)、氟芬太尼(30.4%)、曲马多(30.4%)和利多卡因(30.4%)的阳性率。质谱结果表明利多卡因在赛拉嗪试纸类型中引发了3例假阳性和0例假阴性。还观察到总共0例假阴性和1例假阳性。

讨论

赛拉嗪出现在美墨边境,需要公共卫生干预。高利多卡因阳性率使通过试纸临床检测赛拉嗪变得复杂。发现赛拉嗪在尿液中比在用具样本中更普遍。需要进行确证性尿液研究,以更好地了解使用试纸进行毒理学检测可能出现的并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5321/11370493/aff4861d8597/nihpp-2024.08.19.24312273v2-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验